Home › Paraganglioma › Pennsylvania › Philadelphia
Paraganglioma clinical trials in Philadelphia, PA
3 studies for Paraganglioma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
RecruitingPhase 2
- PENN, Philadelphia
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
Recruiting
- Penn Medicine, Philadelphia
In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma
RecruitingEarly phase 1
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Paraganglioma trials in other cities
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.